Celia Morgan - Ketamine: The Trojan Horse Tranquilliser

Celia Morgan presents ketamine as a gateway to integrating psychedelic-assisted therapy into the NHS. By leveraging the existing clinical use of ketamine, she argues it serves as a vehicle to roll out psychedelic states, focusing on access beyond the current privileged demographic. The strategy is framed as a long-term goal to transform mental healthcare from within by working through established structures. Morgan highlights the inherent challenges of scaling, including potential addiction risks and the need for a safe therapeutic container. She emphasizes the necessity of combining ketamine with evidence-based therapy to manage the experience effectively. Despite its schedule 2 status making it accessible, careful handling remains critical for its safe integration into existing healthcare frameworks.